IJ

Two decades of research have established that Nuclear Factor-kappa B (NF-kappa B) signaling plays a critical role in reprogramming the fat cell transcriptome towards inflammation in response to overnutrition and metabolic stress. Several groups have suggested that inhibition of NF-kappa B signaling could have metabolic benefits for obesity-associated adipose tissue inflammation. However, two significant problems arise with this approach. The first is how to deliver general NF-kappa B inhibitors into adipocytes without allowing these compounds to disrupt normal functioning in cells of the immune system. The second issue is that general inhibition of canonical NF-kappa B signaling in adipocytes will likely lead to a massive increase in adipocyte apoptosis under conditions of metabolic stress, leading full circle into a secondary inflammation (However, this problem may not be true for non-canonical NF-kappa B signaling.). This review will focus on the research that has examined canonical and non-canonical NF-kappa B signaling in adipocytes, focusing on genetic studies that examine loss-of-function of NF-kappa B specifically in fat cells. Although the development of general inhibitors of canonical NF-kappa B signaling seems unlikely to succeed in alleviating adipose tissue inflammation in humans, the door remains open for more targeted therapeutics. In principle, these would include compounds that interrogate NF-kappa B DNA binding, protein-protein interactions, or post-translational modifications that partition NF-kappa B activity towards some genes and away from others in adipocytes. I also discuss the possibility for inhibitors of non-canonical NF-kappa B signaling to realize success in mitigating fat cell dysfunction in obesity. To plant the seeds for such approaches, much biochemical digging in adipocytes remains; this includes identifying-in an unbiased manner - NF-kappa B direct and indirect targets, genomic DNA binding sites for all five NF-kappa B subunits, NF-kappa B protein-protein interactions, and post-translational modifications of NF-kappa B in fat cells.

NF-kappaB; adipocytes; obesity; inflammation